共有 50 笔近期内部人交易记录记录，涉及 iTeos Therapeutics, Inc. (ITOS), 包括 31 笔买入 和 14 笔卖出. 内部人买入总额为 $83.46M 内部人卖出总额为 $25.43M.
近期活跃的重要内部人包括 Detheux Michel, Hallal David, Ecor1 Capital, Llc. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — ITOS
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2025-06-10 |
Detheux Michel |
Chief Executive Officer |
知情卖出 |
43,883 |
$10.02 |
$439.71K |
- |
| 2025-06-09 |
Detheux Michel |
Chief Executive Officer |
知情卖出 |
43,882 |
$10.03 |
$440.14K |
- |
| 2025-06-06 |
Hallal David |
Director |
期权行权（卖出） |
38,228 |
$4.30 |
$164.38K |
- |
| 2025-06-06 |
Detheux Michel |
Chief Executive Officer |
知情卖出 |
43,882 |
$10.21 |
$448.04K |
- |
| 2025-06-05 |
Hallal David |
Director |
知情卖出 |
38,227 |
$10.15 |
$388K |
- |
| 2025-06-05 |
Detheux Michel |
Chief Executive Officer |
知情卖出 |
43,882 |
$10.15 |
$445.4K |
- |
| 2025-06-04 |
Hallal David |
Director |
知情卖出 |
38,227 |
$10.07 |
$384.95K |
- |
| 2025-06-04 |
Detheux Michel |
Chief Executive Officer |
知情卖出 |
43,883 |
$10.10 |
$443.22K |
- |
| 2025-05-15 |
Ecor1 Capital, Llc |
10 Percent Owner |
知情买入 |
3,300,000 |
$8.00 |
$26.4M |
10,688,978 |
| 2025-05-14 |
Ecor1 Capital, Llc |
10 Percent Owner |
知情买入 |
1,658,978 |
$7.41 |
$12.29M |
7,388,978 |
| 2025-05-13 |
Ecor1 Capital, Llc |
10 Percent Owner |
未知 |
- |
- |
- |
5,730,000 |
| 2025-05-13 |
Van Hauwermeiren Timothy |
Director |
期权行权（卖出） |
22,346 |
$4.30 |
$96.09K |
- |
| 2025-05-13 |
Gadicke Ansbert |
Other: Former 10% Owner |
知情卖出 |
1,031,931 |
$8.06 |
$8.32M |
3,452,797 |
| 2025-05-13 |
Mpm Bioventures 2014, L.p. |
Other: Former 10% Owner |
知情卖出 |
630,191 |
$8.06 |
$5.08M |
2,108,594 |
| 2025-05-13 |
Mpm Bioventures 2018, L.p. |
Other: Former 10% Owner |
知情卖出 |
630,191 |
$8.06 |
$5.08M |
2,108,594 |
| 2025-03-07 |
Gall Matthew |
Chief Financial Officer |
限制性股票授予 (RSU) |
24,000 |
- |
- |
89,429 |
| 2025-03-07 |
Detheux Michel |
Chief Executive Officer |
限制性股票授予 (RSU) |
77,000 |
- |
- |
135,903 |
| 2025-03-07 |
Call Matthew |
Chief Operating Officer |
限制性股票授予 (RSU) |
145,000 |
$7.05 |
$1.02M |
145,000 |
| 2025-03-07 |
Mcgrath Yvonne |
Chief Scientific Officer |
限制性股票授予 (RSU) |
15,300 |
- |
- |
46,300 |
| 2024-12-06 |
Feltquate David |
Chief Medical Officer |
限制性股票授予 (RSU) |
47,000 |
- |
- |
47,000 |
| 2024-11-19 |
Gall Matthew |
Chief Financial Officer |
知情买入 |
5,000 |
$7.73 |
$38.64K |
65,429 |
| 2024-08-08 |
Detheux Michel |
Chief Executive Officer |
赠与（送出） |
442,800 |
$11.58 |
$5.13M |
147,600 |
| 2024-08-01 |
Feltquate David |
Chief Medical Officer |
限制性股票授予 (RSU) |
350,000 |
$17.46 |
$6.11M |
350,000 |
| 2024-07-31 |
Feltquate David |
Officer |
未知 |
- |
- |
- |
- |
| 2024-06-11 |
Rhoads Ann D |
Director |
限制性股票授予 (RSU) |
24,200 |
$16.32 |
$394.94K |
24,200 |
| 2024-06-11 |
Hallal David |
Director |
限制性股票授予 (RSU) |
24,200 |
$16.32 |
$394.94K |
24,200 |
| 2024-06-11 |
Davis Aaron I. |
Director |
限制性股票授予 (RSU) |
24,200 |
$16.32 |
$394.94K |
24,200 |
| 2024-06-11 |
Ho Tony W |
Director |
限制性股票授予 (RSU) |
24,200 |
$16.32 |
$394.94K |
24,200 |
| 2024-06-11 |
Iannone Robert |
Director |
限制性股票授予 (RSU) |
24,200 |
$16.32 |
$394.94K |
24,200 |
| 2024-06-11 |
Van Hauwermeiren Timothy |
Director |
限制性股票授予 (RSU) |
24,200 |
$16.32 |
$394.94K |
24,200 |
| 2024-06-11 |
Desimone Jill |
Director |
限制性股票授予 (RSU) |
24,200 |
$16.32 |
$394.94K |
24,200 |
| 2024-06-11 |
Lee David K |
Director |
限制性股票授予 (RSU) |
24,200 |
$16.32 |
$394.94K |
24,200 |
| 2024-05-12 |
Ra Capital Management, L.p. |
Other: Former 10% Owner |
其他（卖出） |
900,000 |
- |
- |
2,545,510 |
| 2024-05-10 |
Ra Capital Management, L.p. |
Other: Former 10% Owner |
知情买入 |
5,714,285 |
$0.00 |
$5.71K |
5,714,285 |
| 2024-05-10 |
Boxer Capital, Llc |
Other: See Remarks |
限制性股票授予 (RSU) |
1,142,857 |
$17.50 |
$20M |
2,946,915 |
| 2024-03-07 |
Desimone Jill |
Officer |
未知 |
- |
- |
- |
- |
| 2024-03-07 |
Desimone Jill |
Director |
限制性股票授予 (RSU) |
44,766 |
$11.58 |
$518.39K |
44,766 |
| 2024-03-07 |
Gall Matthew |
Chief Financial Officer |
限制性股票授予 (RSU) |
163,200 |
$11.58 |
$1.89M |
163,200 |
| 2024-03-07 |
Detheux Michel |
Chief Executive Officer |
限制性股票授予 (RSU) |
590,400 |
$11.58 |
$6.84M |
590,400 |
| 2024-03-07 |
Call Matthew |
Chief Operating Officer |
限制性股票授予 (RSU) |
225,000 |
$11.58 |
$2.61M |
225,000 |
| 2024-03-07 |
Mcgrath Yvonne |
Chief Scientific Officer |
限制性股票授予 (RSU) |
153,600 |
$11.58 |
$1.78M |
153,600 |
| 2023-12-05 |
Gall Matthew |
Chief Financial Officer |
限制性股票授予 (RSU) |
41,000 |
- |
- |
60,429 |
| 2023-12-05 |
Detheux Michel |
Chief Executive Officer |
限制性股票授予 (RSU) |
30,000 |
- |
- |
58,903 |
| 2023-12-05 |
Call Matthew |
Chief Operating Officer |
限制性股票授予 (RSU) |
44,000 |
- |
- |
137,898 |
| 2023-12-05 |
Mcgrath Yvonne |
Chief Scientific Officer |
限制性股票授予 (RSU) |
31,000 |
- |
- |
31,000 |
| 2023-12-05 |
Lee David K |
Officer |
未知 |
- |
- |
- |
- |
| 2023-12-05 |
Lee David K |
Director |
限制性股票授予 (RSU) |
44,766 |
$9.84 |
$440.5K |
44,766 |
| 2023-10-12 |
Gall Matthew |
Chief Financial Officer |
知情买入 |
5,000 |
$8.37 |
$41.85K |
19,429 |
| 2023-08-23 |
Boxer Capital, Llc |
Officer |
知情卖出 |
219,638 |
$16.87 |
$3.71M |
1,804,058 |
| 2023-06-13 |
Rhoads Ann D |
Director |
限制性股票授予 (RSU) |
22,383 |
$14.77 |
$330.6K |
22,383 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
